UniSa - IRIS Institutional Research Information System

BARONE, Paolo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 35.265
NA - Nord America 28.687
EU - Europa 10.554
SA - Sud America 2.493
Continente sconosciuto - Info sul continente non disponibili 1.125
AF - Africa 301
OC - Oceania 212
Totale 78.637
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 27.952
HK - Hong Kong 23.379
SG - Singapore 5.254
IT - Italia 4.356
CN - Cina 2.607
BR - Brasile 1.855
VN - Vietnam 1.749
UA - Ucraina 1.442
RU - Federazione Russa 950
DE - Germania 881
IE - Irlanda 655
FR - Francia 561
KR - Corea 485
TR - Turchia 443
CA - Canada 380
SE - Svezia 358
GB - Regno Unito 334
FI - Finlandia 324
BD - Bangladesh 295
IN - India 272
AR - Argentina 235
EE - Estonia 149
MX - Messico 149
JP - Giappone 133
NL - Olanda 106
IQ - Iraq 105
NZ - Nuova Zelanda 105
AU - Australia 101
EC - Ecuador 96
PL - Polonia 86
CO - Colombia 84
ES - Italia 74
ZA - Sudafrica 74
PK - Pakistan 72
ID - Indonesia 70
AT - Austria 65
VE - Venezuela 64
UZ - Uzbekistan 52
CL - Cile 51
MA - Marocco 50
PY - Paraguay 41
MY - Malesia 39
SA - Arabia Saudita 39
JM - Giamaica 38
CR - Costa Rica 37
CZ - Repubblica Ceca 34
KE - Kenya 32
PH - Filippine 29
IL - Israele 25
EG - Egitto 23
AE - Emirati Arabi Uniti 22
AZ - Azerbaigian 22
PE - Perù 22
UY - Uruguay 21
BO - Bolivia 20
CH - Svizzera 20
DZ - Algeria 20
ET - Etiopia 20
HN - Honduras 20
JO - Giordania 19
DO - Repubblica Dominicana 18
LT - Lituania 18
EU - Europa 16
AL - Albania 15
OM - Oman 15
TN - Tunisia 15
BE - Belgio 14
LB - Libano 14
NP - Nepal 14
PR - Porto Rico 14
GT - Guatemala 13
KZ - Kazakistan 13
BG - Bulgaria 12
NI - Nicaragua 12
SV - El Salvador 12
BA - Bosnia-Erzegovina 9
BY - Bielorussia 9
MN - Mongolia 9
PS - Palestinian Territory 9
PT - Portogallo 9
BW - Botswana 8
GE - Georgia 8
GR - Grecia 8
IR - Iran 8
CI - Costa d'Avorio 7
DK - Danimarca 7
HU - Ungheria 7
PA - Panama 7
BH - Bahrain 6
KG - Kirghizistan 6
KH - Cambogia 6
QA - Qatar 6
RS - Serbia 6
SN - Senegal 6
SY - Repubblica araba siriana 6
TT - Trinidad e Tobago 6
BS - Bahamas 5
MD - Moldavia 5
ME - Montenegro 5
MK - Macedonia 5
Totale 77.384
Salva come PNG Salva come JPEG
Città #
Hong Kong 23.346
Ann Arbor 4.156
San Jose 2.780
Singapore 2.561
Wilmington 2.258
Jacksonville 1.740
Milan 1.728
Princeton 1.637
Chandler 1.536
Ashburn 1.402
Dallas 1.228
Council Bluffs 1.143
Houston 771
Woodbridge 620
Dublin 614
Beijing 579
The Dalles 490
Lauterbourg 479
Dong Ket 459
Rome 437
Ho Chi Minh City 414
Nanjing 399
New York 380
Andover 368
Izmir 365
Los Angeles 363
Moscow 316
Boardman 299
Santa Clara 297
Hanoi 294
Pellezzano 264
Düsseldorf 216
Mestre 203
Naples 199
São Paulo 181
Norwalk 146
Tallinn 146
Figino 139
Shenyang 134
Buffalo 132
Fairfield 131
Salerno 128
Hebei 121
Munich 121
Tokyo 119
Memphis 116
Changsha 113
Nanchang 108
Dearborn 107
Phoenix 103
Chicago 97
Frankfurt am Main 95
Jiaxing 85
Brooklyn 84
Montreal 82
Turin 79
Da Nang 69
Orem 69
San Francisco 68
Warsaw 67
Nuremberg 65
Denver 61
Rio de Janeiro 61
Redwood City 60
Atlanta 59
San Diego 59
Haiphong 58
Pune 56
Tianjin 56
Toronto 56
Amsterdam 53
Columbus 53
Seattle 51
Philadelphia 48
Tashkent 47
Boston 46
Stockholm 46
Mexico City 45
Baghdad 44
Washington 44
Auckland 43
Sydney 43
Curitiba 42
London 41
Belo Horizonte 39
Bologna 39
Seoul 39
Chennai 38
Brasília 37
Charlotte 37
Cambridge 35
Turku 35
West Jordan 35
Johannesburg 34
Ottawa 32
Poplar 31
Shanghai 31
Quito 30
Florence 29
Jinan 29
Totale 58.968
Salva come PNG Salva come JPEG
Nome #
Retinal thinning in progressive supranuclear palsy: differences with healthy controls and correlation with clinical variables 1.214
Step length predicts executive dysfunction in Parkinson’s disease: a 3-year prospective study 1.009
Longitudinal change of energy expenditure, body composition and dietary habits in Progressive Supranuclear Palsy patients 973
Managing Device-Aided Treatments in Parkinson's Disease in Times of COVID-19 942
Trial of Deferiprone in Parkinson's Disease 696
Sex Differences in Parkinson’s Disease: From Bench to Bedside 655
Quantitative gait assessment in Parkinsonian patients with or without Mild Cognitive Impairment 625
Prevalence and associated features of self-reported freezing of gait in Parkinson disease: The DEEP FOG study 609
Alteration of endosomal trafficking is associated with early-onset parkinsonism caused by SYNJ1 mutations 603
Cognitive impairment in nondemented Parkinson's disease. 590
Gender differences in microRNA expression in levodopa-naive PD patients 583
Success rate, efficacy, and safety/tolerability of overnight switching from immediate- to extended-release pramipexole in advanced Parkinson's disease. 556
Insulin-like growth factor-1 predicts cognitive functions at 2-year follow-up in early, drug-naïve Parkinson's disease. 552
Cognitive dysfunctions and pathological gambling in patients with Parkinson's disease. 549
Gait Analysis in Progressive Supranuclear Palsy Phenotypes. 548
A simulation tool to plan daily nurse requirements 543
Relationship Between Orthostatic Hypotension and Cognitive Functions in Multiple System Atrophy: A Longitudinal Study 539
Apparent diffusion coefficient measurements of the middle cerebellar peduncle differentiate the Parkinson variant of MSA from Parkinson's disease and progressive supranuclearpalsy. 527
Combined regional T1w/T2w ratio and voxel-based morphometry in multiple system atrophy: A follow-up study 522
Cognitive dysfunctions and pathological gambling in patients with Parkinson's disease. Apr 30;24(6):899-905.PMID: 19205072 488
Psychometric properties of the Beck Depression Inventory-II in progressive supranuclear palsy 485
Quality of Life and Nonmotor Symptoms in Parkinson's Disease 476
White matter changes and the development of motor phenotypes in de novo Parkinson's Disease 464
Motor and Sensory Features of Cervical Dystonia Subtypes: Data From the Italian Dystonia Registry 455
Treatment of nocturnal disturbances and excessive daytime sleepiness in Parkinson's disease. 445
Randomized, double-blind, multicenter evaluation of pramipexole extended release once daily in early Parkinson's disease. 443
Default-mode network connectivity in cognitively unimpaired patients with Parkinson disease 427
Rare causes of early-onset dystonia-parkinsonism with cognitive impairment: a de novo PSEN-1 mutation 418
Fist-Palm Test May Identify Mild Cognitive Impairment and Freezing of Gait in Parkinson's Disease: A Machine Learning Approach 411
The progression of non-motor symptoms in Parkinson's disease and their contribution to motor disability and quality of life. 408
Fist-Palm Test (FiPaT): a bedside motor tool to screen for global cognitive status 401
Energy expenditure, body composition and dietary habits in progressive supranuclear palsy 398
Neurotransmission in Parkinson's disease: beyond dopamine. 384
Apathy evaluation scale-informant version in progressive supranuclear palsy: Psychometric properties and clinical correlates 364
Effects of Safinamide on Pain in Fluctuating Parkinson's Disease Patients: A Post-Hoc Analysis 362
Improving the Efficacy of Botulinum Toxin for Cervical Dystonia: A Scoping Review 354
Clinical and Molecular Characterization of a Novel Progranulin Deletion Associated with Different Phenotypes 342
Resting-state brain connectivity in patients with Parkinson's disease and freezing of gait. 341
Bilateral facial palsy after COVID-19 vaccination 339
A longitudinal study of cognitive dysfunction in patients affected by Parkinson’s disease with and without freezing of gait 336
Mitochondrial DNA haplogroup K is associated with a lower risk of Parkinson'sdisease in Italians 332
Magnetic resonance T1w/T2w ratio and voxel-based morphometry in multiple system atrophy 330
A novel phenotype in an Italian family with a rare progranulin mutation 324
Extended-release pramipexole in advanced Parkinson disease: a randomized controlled trial 318
Trial of Cinpanemab in Early Parkinson's Disease 307
Dual-task-related gait patterns as possible marker of precocious and subclinical cognitive alterations in Parkinson disease 306
Association study between the LINGO1 gene and Parkinson's disease in the Italian population 306
Effect of Global Postural Rehabilitation program on spatiotemporal gait parameters of parkinsonian patients: a three-dimensional motion analysis study. 294
Anxiety is associated with striatal dopamine transporter availability in newly diagnosed untreated Parkinson's disease patients. 284
Cognitive performance and neuropsychiatric symptoms in early, untreated Parkinson's disease 283
Classifying Different Stages of Parkinson’s Disease Through Random Forests 276
Validation of the Italian version of Parkinson's Disease-Cognitive Rating Scale (PD-CRS) 269
Metabolomics in Parkinson's disease 268
Hypomorphic NOTCH3 mutation in an Italian family with CADASIL features 255
Intraocular pressure and choroidal thickness postural changes in multiple system atrophy and Parkinson's disease 251
A Bayesian approach to Essential Tremor plus: A preliminary analysis of the TITAN cohort 248
Validation of an Italian version of the 40-item University of Pennsylvania Smell Identification Test that is physician administered: our experience on one hundred and thirty-eight healthy subjects 228
Apathy and striatal dopamine transporter levels in de-novo, untreated Parkinson's disease patients 221
Apoptotic mechanisms in mutant LRRK2-mediated cell death. 220
Lower serum uric acid is associated with mild cognitive impairment in early Parkinson's disease: a 4-year follow-up study 218
A neuropsychological longitudinal study in Parkinson's patients with and without hallucinations. 215
Progression of multiple system atrophy (MSA): a prospective natural history studyby the European MSA Study Group (EMSA SG) 213
Personality in Parkinson's disease: Clinical, behavioural and cognitive correlates 213
Axial motor clues to identify atypical parkinsonism: A multicentre European cohort study 212
Linguistic, psychometric validation and diagnostic ability assessment of an Italian version of a 19-item wearing-off questionnaire for wearing-off detection in Parkinson's disease. 207
The natural history of multiple system atrophy: A prospective European cohort study 207
Imaging of dopaminergic dysfunction with [123I]FP-CIT SPECT in early-onset parkindisease 206
Clinical and dopamine transporter imaging characteristics of non-manifest LRRK2 and GBA mutation carriers in the Parkinson's Progression Markers Initiative (PPMI): a cross-sectional study 205
SAND: a Screening for Aphasia in NeuroDegeneration. Development and normative data 204
Validation of the Italian version of carers’ quality-of-life questionnaire for parkinsonism (PQoL Carer) in progressive supranuclear palsy 204
Anxiety in early Parkinson's disease: Validation of the Italian observer-rated version of the Parkinson Anxiety Scale (OR-PAS) 202
Apathy in untreated, de novo patients with Parkinson’s disease: validation study of Apathy Evaluation Scale 197
Patient-reported convenience of once-daily versus three-times-daily dosing during long-term studies of pramipexole in early and advanced Parkinson's disease. 196
A window into the mind-brain-body interplay: Development of diagnostic, prognostic biomarkers, and rehabilitation strategies in functional motor disorders 191
Pisa syndrome in Parkinson's disease and parkinsonism: clinical features, pathophysiology, and treatment 189
MR imaging index for differentiation of progressive supranuclear palsy from Parkinson disease and the Parkinson variant of multiple system atrophy. 187
Olfaction in Homozygous and Heterozygous SYNJ1 Arg258Gln Mutation Carriers 187
Adherence to anti-Parkinson drug therapy in the ?REASON? sample of Italian patients with Parkinson?s disease: the linguistic validation of the Italian version of the ?Morisky Medical Adherence scale-8 items? 185
Measurements of Postural Sway to Classify Freezing of Gait in Parkinson's Disease 184
Accuracy of clinical diagnostic criteria for Friedreich'sataxia. 183
Machine learning can detect the presence of Mild cognitive impairment in patients affected by Parkinson’s Disease 183
Application of the mPSPRS to the Salerno Cohort and a Comparison Between PSP-RS and vPSP 183
Cerebellar ataxia associated with subclinical celiac disease responding togluten-free diet 178
LRP10 genetic variants in familial Parkinson's disease and dementia with Lewy bodies: a genome-wide linkage and sequencing study 176
A Four-Year Longitudinal Study on Restless Legs Syndrome in Parkinson Disease 175
Cognitive performances and DAT imaging in early Parkinson's disease with mild cognitive impairment: a preliminary study 174
A randomized clinical trial to evaluate the effects of rasagiline on depressive symptoms in non-demented Parkinson's disease patients 173
APP-Related Corticobasal Syndrome: Expanding the List of Corticobasal Degeneration Look Alikes 172
Neuropsychological correlates of Pisa syndrome in patients with Parkinson's disease 170
Quitting smoking: An early non-motor feature of Parkinson's disease? 169
Default-mode network connectivity in cognitively unimpaired patients with Parkinson disease 169
Serum miR-30c-5p is a potential biomarker for multiple system atrophy 169
Essential tremor plus rest tremor: current concepts and controversies 166
Abnormal eating behaviors in progressive supranuclear palsy. 166
Biomechanics Parameters of Gait Analysis to Characterize Parkinson's Disease: A Scoping Review 165
A two-year follow-up study of executive dysfunctions in parkinsonian patients with freezing of gait at on-state. 162
Pramipexole for the treatment of depressive symptoms in patients with Parkinson disease: a randomized, double blind, placebo controlled trial 162
Are granular osmiophilic material deposits an epiphenomenon in CADASIL? 162
An easy tool to improve accuracy in pre-diagnostic Parkinson's disease population 162
Normative data for the Montreal Cognitive Assessment in an Italian population sample 162
Totale 34.299
Salva come PNG Salva come JPEG
Categoria #
all - tutte 234.726
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 234.726
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.597 0 0 14 25 23 16 40 112 405 368 356 1.238
2022/20234.002 472 174 97 355 656 927 20 382 628 18 187 86
2023/20242.059 159 310 110 162 100 197 86 131 71 138 175 420
2024/20256.305 260 60 145 369 216 669 731 686 911 692 741 825
2025/202643.681 4.870 11.165 9.973 1.342 2.392 1.264 4.019 842 1.108 2.363 796 3.547
2026/20273.921 1.099 714 2.108 0 0 0 0 0 0 0 0 0
Totale 78.637